131 related articles for article (PubMed ID: 25178683)
1. Improving cervical cancer screening attendance in Finland.
Virtanen A; Anttila A; Luostarinen T; Malila N; Nieminen P
Int J Cancer; 2015 Mar; 136(6):E677-84. PubMed ID: 25178683
[TBL] [Abstract][Full Text] [Related]
2. [Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].
Virtanen A; Nieminen P; Malila N; Luostarinen T; Anttila A
Duodecim; 2013; 129(16):1709-17. PubMed ID: 24069641
[TBL] [Abstract][Full Text] [Related]
3. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial.
Virtanen A; Nieminen P; Luostarinen T; Anttila A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1960-9. PubMed ID: 21752985
[TBL] [Abstract][Full Text] [Related]
4. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
Virtanen A; Anttila A; Nieminen P
BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
[TBL] [Abstract][Full Text] [Related]
5. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.
Virtanen A; Anttila A; Luostarinen T; Nieminen P
Int J Cancer; 2011 Jun; 128(11):2681-7. PubMed ID: 20669228
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population-based informatics prompted reminder on screening rates.
MacLaughlin KL; Swanson KM; Naessens JM; Angstman KB; Chaudhry R
J Eval Clin Pract; 2014 Apr; 20(2):136-43. PubMed ID: 24237657
[TBL] [Abstract][Full Text] [Related]
7. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer.
Eaker S; Adami HO; Granath F; Wilander E; Sparén P
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):346-54. PubMed ID: 15006907
[TBL] [Abstract][Full Text] [Related]
8. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
9. Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.
Karjalainen L; Anttila A; Nieminen P; Luostarinen T; Virtanen A
BMC Cancer; 2016 Mar; 16():221. PubMed ID: 26979237
[TBL] [Abstract][Full Text] [Related]
10. Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
Paulauskiene J; Ivanauskiene R; Skrodeniene E; Petkeviciene J
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500116
[No Abstract] [Full Text] [Related]
11. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
[TBL] [Abstract][Full Text] [Related]
12. Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme.
Enerly E; Bonde J; Schee K; Pedersen H; Lönnberg S; Nygård M
PLoS One; 2016; 11(4):e0151978. PubMed ID: 27073929
[TBL] [Abstract][Full Text] [Related]
13. Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?
Rozemeijer K; de Kok IM; Naber SK; van Kemenade FJ; Penning C; van Rosmalen J; van Ballegooijen M
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):773-82. PubMed ID: 25432954
[TBL] [Abstract][Full Text] [Related]
14. Self-sampling experiences among non-attendees to cervical screening.
Virtanen A; Nieminen P; Niironen M; Luostarinen T; Anttila A
Gynecol Oncol; 2014 Dec; 135(3):487-94. PubMed ID: 25284037
[TBL] [Abstract][Full Text] [Related]
15. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
16. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
17. Mortality audit of the Finnish cervical cancer screening program.
Lönnberg S; Nieminen P; Luostarinen T; Anttila A
Int J Cancer; 2013 May; 132(9):2134-40. PubMed ID: 22987437
[TBL] [Abstract][Full Text] [Related]
18. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.
Giorgi Rossi P; Fortunato C; Barbarino P; Boveri S; Caroli S; Del Mistro A; Ferro A; Giammaria C; Manfredi M; Moretto T; Pasquini A; Sideri M; Tufi MC; Cogo C; Altobelli E;
Br J Cancer; 2015 Feb; 112(4):667-75. PubMed ID: 25633037
[TBL] [Abstract][Full Text] [Related]
19. Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention.
Lönnberg S; Andreassen T; Engesæter B; Lilleng R; Kleven C; Skare A; Johansson K; Fredheim CS; Tropé A
BMJ Open; 2016 Nov; 6(11):e013728. PubMed ID: 28186949
[TBL] [Abstract][Full Text] [Related]
20. Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.
Nieminen P; Hakama M; Tarkkanen J; Anttila A
Int J Cancer; 2002 Jun; 99(5):732-6. PubMed ID: 12115508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
